Patents by Inventor Priscilla A. Swanson

Priscilla A. Swanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120171235
    Abstract: The present invention relates generally to assays for the detection of Xenotropic Murine Leukemia Virus-related Retrovirus (“XMRV”) and diseases associated with XMRV infection. Additionally, the invention relates to specific XMRV antigens capable of inducing an immunogenic response as well as XMRV-related nucleic acids having significant diagnostic, screening, and therapeutic utilities.
    Type: Application
    Filed: March 7, 2012
    Publication date: July 5, 2012
    Inventors: Xiaoxing Qiu, John R. Hackett, JR., Ka-Cheung X. Luk, Priscilla Swanson
  • Patent number: 8183349
    Abstract: The present invention relates generally to assays for the detection of Xenotropic Murine Leukemia Virus-related Retrovirus (“XMRV”) and diseases associated with XMRV infection. Additionally, the invention relates to specific XMRV antigens capable of inducing an immunogenic response as well as XMRV-related nucleic acids having significant diagnostic, screening, and therapeutic utilities.
    Type: Grant
    Filed: June 30, 2010
    Date of Patent: May 22, 2012
    Assignee: Abbott Laboratories
    Inventors: Xiaoxing Qiu, John R. Hackett, Jr., Ka-Cheung X. Luk, Priscilla Swanson
  • Publication number: 20110135674
    Abstract: The present invention relates generally to assays for the detection of Xenotropic Murine Leukemia Virus-related Retrovirus (“XMRV”) and diseases associated with XMRV infection. Additionally, the invention relates to specific XMRV antigens capable of inducing an immunogenic response as well as XMRV-related nucleic acids having significant diagnostic, screening, and therapeutic utilities.
    Type: Application
    Filed: June 30, 2010
    Publication date: June 9, 2011
    Applicants: ABBOTT LABORATORIES, THE CLEVELAND CLINIC FOUNDATION
    Inventors: XIAOXING QIU, JAYDIP DAS GUPTA, JOHN R. HACKETT, JR., KA-CHEUNG X. LUK, ROBERT SILVERMAN, PRISCILLA SWANSON
  • Publication number: 20110137015
    Abstract: The present invention relates generally to assays for the detection of Xenotropic Murine Leukemia Virus-related Retrovirus (“XMRV”) and diseases associated with XMRV infection. Additionally, the invention relates to specific XMRV antigens capable of inducing an immunogenic response as well as XMRV-related nucleic acids having significant diagnostic, screening, and therapeutic utilities.
    Type: Application
    Filed: June 30, 2010
    Publication date: June 9, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: XIAOXING QIU, JOHN R. HACKETT, JR., KA-CHEUNG X. LUK, PRISCILLA SWANSON
  • Patent number: 6852491
    Abstract: Oligonucleotide primer sets, probes, and combinations of the primer sets and probes are provided herein. These reagents are useful for amplifying and detecting HIV-1 target sequences in a test sample.
    Type: Grant
    Filed: September 4, 2001
    Date of Patent: February 8, 2005
    Assignee: Abbott Laboratories
    Inventors: Barbara J. Harris, John R. Hackett, Jr., Priscilla Swanson, Klara Abravaya, Sushil G. Devare, Jacek J. Gorzowski, Claudia A. Esping, Ning Tang
  • Publication number: 20030148280
    Abstract: Oligonucleotide primer sets, probes, and combinations of the primer sets and probes are provided herein. These reagents are useful for amplifying and detecting HIV-1 target sequences in a test sample.
    Type: Application
    Filed: September 4, 2001
    Publication date: August 7, 2003
    Inventors: Barbara J. Harris, John R. Hackett, Priscilla Swanson, Klara Abravaya, Sushil G. Devare, Jacek J. Gorzowski, Claudia A. Esping, Ning Tang
  • Patent number: 6406841
    Abstract: The present invention relates generally to a novel human T-cell lymphotropic, or leukemia, virus type II (HTLV-II) isolate designated NRA. HTLV-IINRA was originally isolated from a patient with atypical hairy cell leukemia. Preliminary restriction analysis of this isolate demonstrated that it differs genetically from the prototypical HTLV-II isolate Mo. HTLV-IINRA proviral molecular clones were obtained and the entire nucleotide sequence of the virus ascertained. The claimed invention is particularly directed toward the gp46 and p21e envelope proteins encoded by the env gene. Methods and kits for the detection of HTLV-II antibodies employing these envelope proteins are also described.
    Type: Grant
    Filed: June 20, 1994
    Date of Patent: June 18, 2002
    Assignee: Abbott Laboratories
    Inventors: Helen H. Lee, Priscilla A. Swanson, Kenneth B. Idler, Joseph D. Rosenblatt, Irvin S. Y. Chen, David W. Golde, Eugene Robertson, John E. Stephens, Emerson W. Chan, Mark H. Buytendorp, Joan E. Johnson, Cheryl T. Motley, Michelle Edwards, Cynthia Tate, Bryan Peterson, Peggy Guidinger
  • Publication number: 20020042045
    Abstract: Compositions including lysates, DNA and amino acid sequences derived from HTLV-IINRA are provided. Assays for detecting HTLV infection that employ the disclosed HTLV-IINRA compositions are also provided. Kits for performing HTLV assays are further provided.
    Type: Application
    Filed: June 20, 1994
    Publication date: April 11, 2002
    Inventors: HELEN H. LEE, PRISCILLA A. SWANSON, KENNETH B. IDLER, JOSEPH D. ROSENBELT, RIVIN S. Y. CHEN, DAVID W. GOLDE, EUGENE ROBERTSON, JOHN E. STEPHENS, EMERSON W. CHAN, MARK H. BUYTENDORP, JOAN E. JOHNSON, CHERYL T. MOTLEY, MICHELLE EDWARDS, CYNTHIA TATE, BRYAN PETERSON, PEGGY GUIDINGER